Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Former Newcastle goalkeeper Shaka Hislop has revealed he has prostate cancer. The 56-year-old Hislop who also played in the Premier League for West Ham and Portsmouth said he had been diagnosed with ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...

Doctors Are Sounding the Alarm on Overused CT Scans :warning: A new study from Yale reveals a troubling trend — the use of head CT scans has doubled since 2007, and it could be silently driving up ...

A New York City woman is using her lung cancer survival story to push for early detection, especially among nonsmokers and those in underserved communities. Colette Smith of the Bronx wrote a message ...

The Pelvic Rosetta Classification (PRC) project aimed to develop an interdisciplinary, landmark-based pelvic lymph node map for patients with prostate cancer to improve communication between imaging ...

CT scans identified cancer in 13% of patients with non-specific symptoms, despite a fivefold increase in referrals from GPs from 2012 to 2019. Around 1 in 7 patients were diagnosed with cancer. This ...

QUINCY — Lung cancer is the second most common cancer in both men and women in the United States, taking more lives than breast, colon and prostate cancers combined. In recognition of national Lung ...

PANAMA CITY, Fla. (WJHG/WECP) - Ascension Sacred Heart Bay is expanding its cancer care with the addition of a PET CT scanning machine on its campus, located right next to the cancer care center.

Department of Radiology, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China Introduction: This study was conducted to evaluate any association between extraprostatic extension (EPE) grade with the ...

Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...